Ex Vivo Models and Interpretation of Mechanistic Studies in Hidradenitis Suppurativa.

Current ex vivo and animal models of hidradenitis suppurativa (HS) display issues with fidelity and validity to human disease. Vossen et al.'s Transwell culture system holds potential to reliably assess mechanistic pathways in HS. Consideration of the sites of control tissue and comparison of the Transwell model against skin explant models would increase the validity of this method of inquiry.

• Publication year

  2020

• Venue

  Journal of Investigative Dermatology

• Publication date

  2020-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jid.2020.02.014PMID 32571498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Phase II, Open Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain.

  2020cited by this paper
• Lesional inflammatory profile in Hidradenitis Suppurativa is not solely driven by IL-1.

  2020cited by this paper
• Lessons learned from the development of a hidradenitis suppurativa xenograft mouse model

  2019cited by this paper
• Additive or Synergistic Interactions Between IL-17A or IL-17F and TNF or IL-1β Depend on the Cell Type

  2019cited by this paper
• Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa.

  2019cited by this paper
• The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction.

  2019cited by this paper
• Population‐based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa

  2018cited by this paper
• Population‐based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa

  2018cited by this paper
• Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model

  2018cited by this paper
• Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial.

  2016cited by this paper
• Can Animal Skin Diseases or Current Transgenic Mice Serve as a Model for Hidradenitis Suppurativa?

  2012cited by this paper
• The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling

  2011cited by this paper

• The Inflammatory Landscape of a Whole‐Tissue Explant Model of Hidradenitis Suppurativa

  2025cites this paper
• Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa

  2025cites this paper
• Hidradenitis Suppurativa Preclinical Studies: Models and Results

  2025cites this paper
• Infliximab inhibits TNF-α-dependent activation of the NLRP3/IL-1β pathway in acne inversa

  2024cites this paper
• Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?

  2024cites this paper
• Surgical outcomes of hidradenitis suppurativa: evaluating factors influencing recurrence and complications after 284 complete excisions.

  2024cites this paper
• A Novel Whole Tissue Explant Model of Hidradenitis Suppurativa

  2024cites this paper
• HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa

  2023cites this paper
• Follicular Occlusion and Inflammation

  2022cites this paper
• The pathogenesis of hidradenitis suppurativa: Evolving paradigms in a complex disease

  2022cites this paper
• Epithelialized Tunnels are a Source of Inflammation in Hidradenitis Suppurativa.

  2021cites this paper
• What causes hidradenitis suppurativa ?—15 years after

  2020cites this paper
• Hidradenitis suppurativa is an autoinflammatory keratinization disease: A review of the clinical, histologic, and molecular evidence

  2020cites this paper
• A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance.

  2020cites this paper